PMID- 31909831 OWN - NLM STAT- MEDLINE DCOM- 20200727 LR - 20210402 IS - 1365-2567 (Electronic) IS - 0019-2805 (Print) IS - 0019-2805 (Linking) VI - 159 IP - 4 DP - 2020 Apr TI - CD8alpha(-) conventional dendritic cells control Vbeta T-cell immunity in response to Staphylococcus aureus infection in mice. PG - 404-412 LID - 10.1111/imm.13171 [doi] AB - Dendritic cells (DCs) are potent immune cells that control innate and adaptive immune responses. Previous studies have shown that the DCs are required for protection against Staphylococcus aureus infection. However, the role of conventional DC (cDC) subsets during S. aureus infection in vivo has not been well investigated. In this study, we examined the function of spleen DC subsets in the activation of immunity against S. aureus infection. C57BL/6 mice were infected intravenously with S. aureus and DC and T-cell activation were analyzed in vivo. We found that the spleen CD8alpha(-) cDCs phagocytosed S. aureus more efficiently than type-1 conventional DCs (cDC1s) did. Moreover, the CD8alpha(-) cDCs contributed to the production of pro-inflammatory cytokines in response to S. aureus infection, whereas the cDC1s did not. In addition, infection with S. aureus promoted an increase in the number of Vbeta T cells. The CD4(+) and CD8(+) Vbeta T cells up-regulated the production of interferon-gamma (IFN-gamma) and interleukin-17 (IL-17) in response to S. aureus infection. Importantly, the induction of IFN-gamma and IL-17 production in CD4(+) and CD8(+) Vbeta T cells was mediated by S. aureus-stimulated CD8alpha(-) cDCs, whereas cDC1s failed to promote IFN-gamma and IL-17 production in the cells. Therefore, these data suggested that the spleen CD8alpha(-) cDCs are the main DC subsets for induction of S. aureus superantigen-specific immunity. CI - (c) 2020 John Wiley & Sons Ltd. FAU - Zhang, Wei AU - Zhang W AUID- ORCID: 0000-0002-9262-849X AD - Shanghai Public Health Clinical Center &, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. FAU - Xu, Li AU - Xu L AUID- ORCID: 0000-0002-7883-0448 AD - Shanghai Public Health Clinical Center &, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. FAU - Zhang, Xiaoyan AU - Zhang X AUID- ORCID: 0000-0002-3193-1401 AD - Shanghai Public Health Clinical Center &, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. FAU - Xu, Jianqing AU - Xu J AUID- ORCID: 0000-0003-0896-9273 AD - Shanghai Public Health Clinical Center &, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. FAU - Jin, Jun-O AU - Jin JO AUID- ORCID: 0000-0003-4216-8111 AD - Shanghai Public Health Clinical Center &, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. AD - Department of Medical Biotechnology, Yeungnam University, Gyeongsan, South Korea. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200121 PL - England TA - Immunology JT - Immunology JID - 0374672 RN - 0 (CD8 Antigens) RN - 0 (CD8 antigen, alpha chain) RN - 0 (Il17a protein, mouse) RN - 0 (Interleukin-17) RN - 0 (Receptors, Antigen, T-Cell, alpha-beta) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Animals MH - CD4-Positive T-Lymphocytes/immunology/microbiology/pathology MH - CD8 Antigens/deficiency/genetics/*immunology MH - CD8-Positive T-Lymphocytes/*immunology/microbiology/pathology MH - Cell Lineage/immunology MH - Dendritic Cells/*immunology/microbiology MH - Gene Expression MH - Host-Pathogen Interactions/immunology MH - Immunity, Cellular MH - Interferon-gamma/genetics/immunology MH - Interleukin-17/genetics/immunology MH - Lymphocyte Activation MH - Mice MH - Mice, Inbred C57BL MH - Phagocytosis MH - Receptors, Antigen, T-Cell, alpha-beta/genetics/*immunology MH - Spleen/immunology/microbiology/pathology MH - Staphylococcal Infections/*immunology/microbiology/pathology MH - Staphylococcus aureus/*immunology/pathogenicity PMC - PMC7077999 OTO - NOTNLM OT - Staphylococcus aureus OT - CD8alpha- dendritic cells OT - Vbeta T cells OT - interferon-gamma OT - interleukin-17 COIS- Not applicable. EDAT- 2020/01/08 06:00 MHDA- 2020/07/28 06:00 PMCR- 2021/04/01 CRDT- 2020/01/08 06:00 PHST- 2019/07/26 00:00 [received] PHST- 2020/01/04 00:00 [revised] PHST- 2020/01/06 00:00 [accepted] PHST- 2020/01/08 06:00 [pubmed] PHST- 2020/07/28 06:00 [medline] PHST- 2020/01/08 06:00 [entrez] PHST- 2021/04/01 00:00 [pmc-release] AID - IMM13171 [pii] AID - 10.1111/imm.13171 [doi] PST - ppublish SO - Immunology. 2020 Apr;159(4):404-412. doi: 10.1111/imm.13171. Epub 2020 Jan 21.